Research progress of acute myeloid leukemia: reports from the 57th American Society of Hematology annual meeting
10.3760/cma.j.issn.1009-9921.2016.01.008
- VernacularTitle:急性髓系白血病研究进展:第57届美国血液学会年会报道
- Author:
Jingjing CAO
;
Hui WEI
- Publication Type:Journal Article
- Keywords:
Leukemia;
myeloid;
acute;
American Society of Hematology annual meeting
- From:
Journal of Leukemia & Lymphoma
2016;25(1):26-28
- CountryChina
- Language:Chinese
-
Abstract:
There are several main topics in acute myelogenous leukemia at the 57th American Society of Hematology annual meeting, including the optimization about induction and consolidation chemotherapy for AML, the investigation of targeted drugs in AML first line therapy, the marker for AML MRD monitoring, the differentiation drugs, such as tamibarotene in APL, the definition about refractory AML, the induction therapy for blastic plasmacytoid dendritic cell neoplasm (BPDCN). This article reviewed the research progress of AML in the 57th ASH annual meeting.
